WORK Medical Technology (WOK) Cash & Equivalents (2023 - 2026)

WORK Medical Technology (WOK) has reported Cash & Equivalents for 4 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 63.02% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 63.02% YoY), and the FY2025 full-year result was $4.1 million, down 37.65% from the prior year.
• Cash & Equivalents declined to $3.3 million in Q1 2026 per WOK's latest filing, from $4.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $6.6 million in Q3 2024 and bottomed at $1.6 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $3.5 million across 4 years, with a median of $3.3 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 310.85% in 2024, then tumbled 37.65% in 2025.
• Over 4 years, Cash & Equivalents stood at $1.6 million in 2023, then soared by 310.85% to $6.6 million in 2024, then plunged by 37.65% to $4.1 million in 2025, then declined by 20.42% to $3.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.3 million, $4.1 million, and $2.0 million for Q1 2026, Q3 2025, and Q1 2025 respectively.